 | Replimune Group (NASDAQ:REPL) Upgraded to "Buy" at BidaskClub
marketbeat.com - October 22 at 2:19 AM |
| Replimune Group (NASDAQ:REPL) Upgraded to Hold at BidaskClub
marketbeat.com - September 1 at 7:24 AM |
| Replimune Group (NASDAQ:REPL) Downgraded by Zacks Investment Research
marketbeat.com - August 13 at 7:02 AM |
 | Zacks: Brokerages Expect Replimune Group Inc (NASDAQ:REPL) Will Announce Earnings of -$0.42 Per Share
americanbankingnews.com - October 20 at 7:21 PM |
 | Replimune Appoints Tanya Lewis to the Board of Directors
finance.yahoo.com - October 19 at 7:01 PM |
| Comparing Cellectis (NASDAQ:CLLS) & Replimune Group (NASDAQ:REPL)
americanbankingnews.com - October 18 at 1:13 PM |
| Replimune Group Inc (NASDAQ:REPL) Short Interest Up 35.8% in September
americanbankingnews.com - October 17 at 5:35 PM |
| Replimune Group Inc (NASDAQ:REPL) Insider Pamela Esposito Sells 16,000 Shares
americanbankingnews.com - October 16 at 8:40 PM |
| Replimune Group (NASDAQ:REPL) Trading Up 13% on Analyst Upgrade
americanbankingnews.com - October 15 at 6:18 PM |
| Replimune Group (NASDAQ:REPL) Price Target Raised to $44.00
americanbankingnews.com - October 15 at 10:25 AM |
|
| Barclays Boosts Replimune Group (NASDAQ:REPL) Price Target to $50.00
americanbankingnews.com - October 15 at 9:44 AM |
| Replimune Group (NASDAQ:REPL) Price Target Raised to $51.00 at BMO Capital Markets
americanbankingnews.com - October 15 at 9:44 AM |
| Replimune Group (NASDAQ:REPL) Upgraded to Buy at HC Wainwright
americanbankingnews.com - October 15 at 9:44 AM |
| Replimune Group (NASDAQ:REPL) PT Raised to $50.00
americanbankingnews.com - October 14 at 5:04 PM |
| Chardan Capital Boosts Replimune Group (NASDAQ:REPL) Price Target to $48.00
americanbankingnews.com - October 14 at 5:04 PM |
| Replimune Group (NASDAQ:REPL) Sets New 1-Year High at $31.25
americanbankingnews.com - October 14 at 1:01 PM |
| Replimune Group (NASDAQ:REPL) Stock Price Up 6.9%
americanbankingnews.com - October 5 at 8:11 PM |
| Replimune Group Inc (NASDAQ:REPL) Short Interest Update
americanbankingnews.com - October 1 at 4:51 PM |
| Replimune Group (NASDAQ:REPL) Trading Up 8%
americanbankingnews.com - September 29 at 7:02 PM |
 | Replimune Group Inc
bloomberg.com - August 22 at 8:31 AM |
 | Replimune Group EPS beats by $0.01
seekingalpha.com - August 7 at 7:28 AM |
| Replimune Reports Fiscal First Quarter Financial Results and Provides Corporate Update
finance.yahoo.com - August 7 at 7:28 AM |
| Biodesix Appoints Jean Franchi and Hany Massarany to Board of Directors
finance.yahoo.com - July 20 at 10:09 PM |
| Replimune Group, Inc. (REPL): Hedge Funds Are Reducing Exposure
finance.yahoo.com - June 22 at 2:49 PM |
| Replimune (REPL) Looks Good: Stock Adds 5.8% in Session
finance.yahoo.com - June 11 at 10:01 AM |
| Replimune prices $100M share-offering
seekingalpha.com - June 9 at 7:26 AM |
| Replimune Announces Pricing of Upsized Public Offering
finance.yahoo.com - June 9 at 1:35 AM |
 | BRIEF-Replimune Announces Proposed Public Offering
www.reuters.com - June 8 at 8:35 PM |
| BRIEF-Replimune Group Entered Into Amendment No. 1 To Sales Agreement
www.reuters.com - June 8 at 8:35 PM |
| BRIEF-Replimune Reports Fiscal Q4 And Full Year 2020 Results
www.reuters.com - June 3 at 10:28 PM |
| Replimune lead drug shows benefit in non-melanoma skin cancer
seekingalpha.com - June 3 at 12:23 PM |
| BRIEF-Replimune Provides RP1 Data Update From Phase 2 Cohorts In Melanoma And Non-Melanoma Skin Cancer
www.reuters.com - June 3 at 12:23 PM |
| Replimune Provides RP1 Data Update from its Phase 2 Cohorts in Melanoma and Non-Melanoma Skin Cancer that Strongly Support Replimune’s Ongoing Registration-Directed Clinical Trials with RP1
finance.yahoo.com - June 3 at 7:22 AM |
| Replimune to Provide Data Update on June 3, 2020
finance.yahoo.com - April 30 at 7:45 AM |
|
| Replimune Appoints Dieter Weinand as Chairman and Paolo Pucci to the Board of Directors
finance.yahoo.com - April 2 at 7:30 AM |
| Replimune Reports Third Fiscal Quarter Financial Results and Provides Corporate Update
finance.yahoo.com - February 13 at 9:15 AM |
 | BRIEF-Replimune Provides 2019 Year End Corporate Update And Reviews Expected 2020 Milestones
www.msn.com - January 13 at 4:55 PM |
| Replimune Provides 2019 Year End Corporate Update and Reviews Expected 2020 Milestones
finance.yahoo.com - January 13 at 4:55 PM |
| BRIEF-Replimune Group- Robert Coffin Has Elected To Transition To Take Up Role Of President & Chief Research & Development Officer
www.msn.com - January 9 at 4:51 PM |
| Replimune revamps leadership team
seekingalpha.com - January 9 at 4:51 PM |
| Replimune Announces the Evolution of its Management Team as it Advances Through Later Stage Clinical Development and Prepares for Commercialization
finance.yahoo.com - January 9 at 4:51 PM |
| Replimune to Present at the 38th Annual J.P.Morgan Healthcare Conference
finance.yahoo.com - January 7 at 8:52 AM |
| Replimune Group, Inc. (NASDAQ:REPL): Are Hedge Funds Right About This Stock?
finance.yahoo.com - December 23 at 5:52 PM |
| Replimune appoints Jean M. Franchi as CFO
seekingalpha.com - December 9 at 1:57 PM |
| Replimune Group (REPL) Presents At Piper Jaffray31st Annual Healthcare Conference - Slideshow
seekingalpha.com - December 9 at 1:57 PM |
| Replimune Strengthens Executive Team with the Appointment of Jean Franchi as Chief Financial Officer
finance.yahoo.com - December 9 at 8:57 AM |
| Replimune to Present at the Piper Jaffray 31st Annual Healthcare Conference
finance.yahoo.com - November 26 at 8:06 AM |
| Replimune prices equity offering; shares up 3% premarket
seekingalpha.com - November 14 at 12:35 PM |
| Replimune Announces Pricing of Public Offering
finance.yahoo.com - November 14 at 7:32 AM |
 | REPL Replimune Group, Inc. Common Stock
www.nasdaq.com - November 13 at 11:22 PM |
| Replimune Announces Proposed Public Offering
finance.yahoo.com - November 12 at 6:55 PM |
| Replimune Group EPS misses by $0.01
seekingalpha.com - November 11 at 8:28 AM |
| Replimune Reports Second Fiscal Quarter Financial Results and Provides Corporate Update
finance.yahoo.com - November 11 at 8:28 AM |
